Great point tassie, I agree wholeheartedly..

First 2 Last

Share
Profile

Follow
Whatsamadoovie

3,656 Posts.

699

13/09/17

10:18

Post #: 27178197
Share

Originally posted by TassieTwo ↑

An article today on " 2 Potential Boosters for Improving Checkpoint Inhibition in Cancer "
" Cancer killing viruses are already being used in oncology . Amgen's Inlygic , approved to treat some melanoma patients , is an engineered form of the herpes virus .As a solo treatment it has not been widely effective , but Amgen has been partnered with Merck to test the virus with Keytruda ."

I have never seen Cavatak or Viralytics mentioned by Fierce Pharma .

Message to Viralytics : Isn't about time you got onto Fierce Pharma's radar , making them aware that Viralytics has a better drug currently undergoing several trials with outstanding results . Get the PR machine into action .

Hope they tune into Hot Copper

Expand

Great point tassie, I agree wholeheartedly..

VLA Price at posting: 90.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

NUZ

Neurizon inks $1.5M loan against R&D Tax Rebate

IXR

Ionic Rare Earths falls -7% as momentum slips on vague production update

HAR

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Great point tassie, I agree wholeheartedly..

Top Stories

Neurizon inks $1.5M loan against R&D Tax Rebate

Ionic Rare Earths falls -7% as momentum slips on vague production update

Haranga jumps +7% on Lincoln acquisition

HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic

ASX Market Close: Index rebounds as investors buoyant | July 30, 2025

Featured News